UBS Maintains Neutral on CME Group, Raises Price Target to $310
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $270 to $310.
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $270 to $310.